Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Source: Bloomberg ·
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
BestAIBroker analysis
Finance-aware sentiment: positive (+0.50 on a -1 to +1 scale).